FNY Investment Advisers’s Co-Diagnostics CODX Stock Holding History

FNY Investment Advisers’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-117	Closed	-$3K	–	978
2019 Q1	$3K	Buy	+117	New	+$4.21K	﹤0.01%	553

Other funds holding CODX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

FNY Investment Advisers's CODX Position: Q2 2019 in Review

FNY Investment Advisers sold out of Co-Diagnostics (CODX) in Q2 2019, closing a stake of 117 shares — an estimated $3K sold.

FNY Investment Advisers first reported a position in CODX in Q1 2019 and held it in 1 quarter. The position peaked at $3K in Q1 2019. 11 funds tracked by Wall St. Rank hold CODX as of Q2 2019.

FNY Investment Advisers reported no remaining Co-Diagnostics position as of Q2 2019 after selling out during the quarter.
FNY Investment Advisers sold 117 Co-Diagnostics shares in Q2 2019, an estimated $3K.
FNY Investment Advisers first reported a position in Co-Diagnostics in Q1 2019 and held it in 1 quarter.
FNY Investment Advisers's Co-Diagnostics position peaked at $3K in Q1 2019.
11 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2019.

Based on FNY Investment Advisers's 13F filing for Q2 2019, filed 24 Jul 2019.